FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Alberto Tosetto

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Francesco Rodeghiero; Marco Ruggeri; Alberto Tosetto; Victor Blanchette; James B Bussel; Douglas B Cines; Nichola Cooper; Terry Gernsheimer; Bertrand Godeau; Andreas Greinacher; Paul Imbach; Mehdi Khellaf; Robert J Klaassen; Thomas Kühne; Howard Liebman; Maria Gabriella Mazzucconi; Marc Michel; Adrian Newland; Ingrid Pabinger; Roberto Stasi
Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group.
Roberto Raimondi; Alessandro Rambaldi; Francesco Rodeghiero; Alberto Tosetto; Andrea Bacigalupo; Riccardo Cavazzina; Renato Fanin; Rosi Oneto; Alberto Bosi
Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index: a prospective, multicenter GITMO study.
Alberto Tosetto; T Baglin; M Cushman; S Eichinger; A Iorio; M Marcucci; G Palareti; D Poli; R C Tait; J Douketis
Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Alberto Tosetto (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Francesco Rodeghiero; Marco Ruggeri; Alberto Tosetto; Victor Blanchette; James B Bussel; Douglas B Cines; Nichola Cooper; Terry Gernsheimer; Bertrand Godeau; Andreas Greinacher; Paul Imbach; Mehdi Khellaf; Robert J Klaassen; Thomas Kühne; Howard Liebman; Maria Gabriella Mazzucconi; Marc Michel; Adrian Newland; Ingrid Pabinger; Roberto Stasi
Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group.
Blood 2013;121(14):2596-606.
2012: Roberto Raimondi; Alessandro Rambaldi; Francesco Rodeghiero; Alberto Tosetto; Andrea Bacigalupo; Riccardo Cavazzina; Renato Fanin; Rosi Oneto; Alberto Bosi
Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index: a prospective, multicenter GITMO study.
Blood 2012;120(6):1327-33.
2012: Alberto Tosetto; T Baglin; M Cushman; S Eichinger; A Iorio; M Marcucci; G Palareti; D Poli; R C Tait; J Douketis
Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH).
Journal of thrombosis and haemostasis : JTH 2012;10(6):1019-25.
2012: Giancarlo Castaman; Augusto B Federici; S La Marca; P M Mannucci; F Stufano; Alberto Tosetto; Francesco Rodeghiero
Different bleeding risk in type 2A and 2M von Willebrand disease: a 2-year prospective study in 107 patients.
Journal of thrombosis and haemostasis : JTH 2012;10(4):632-8.
2011: Giancarlo Castaman; Alberto Tosetto
Is a reduced intensity treatment with Rituximab effective in acquired haemophilia A?
Haemophilia : the official journal of the World Federation of Hemophilia 2011;17(5):817-8.
2011: Alberto Tosetto
The unresolved challenge of subjects at intermediate cardiovascular risk.
Internal and emergency medicine 2011;6(4):297-8.
2011: Alberto Tosetto; Giancarlo Castaman; Iris Plug; Francesco Rodeghiero; J C J Eikenboom
Prospective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic evaluation.
Journal of thrombosis and haemostasis : JTH 2011;9(6):1143-8.
2011: Patrizio Prati; Alberto Tosetto; Marco Casaroli; A Bignamini; L Canciani; N Bornstein; G Prati; Pierre Jean Touboul
Carotid plaque morphology improves stroke risk prediction: usefulness of a new ultrasonographic score.
Cerebrovascular diseases (Basel, Switzerland) 2011;31(3):300-4.
2010: Ida Martinelli; P Bucciarelli; Valerio De Stefano; S M Passamonti; M Menegatti; D Tormene; Alberto Tosetto; Pier M Mannucci
Effect of prothrombin 19911 A>G polymorphism on the risk of cerebral sinus-venous thrombosis.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2010;17(12):1482-5.
2010: Giancarlo Castaman; Alberto Tosetto; Anne C Goodeve; Augusto B Federici; Stefan Lethagen; Ulrich Budde; Javier Batlle; Dominique Meyer; Claudine Mazurier; Jenny Goudemand; Jeroen Eikenboom; Reinhard Schneppenheim; Jørgen Ingerslev; David Habart; Frank Hill; Ian R Peake; Francesco Rodeghiero
The impact of bleeding history, von Willebrand factor and PFA-100(®) on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD.
British journal of haematology 2010;151(3):245-51.
2010: Alberto Tosetto
Thrombophilic mutations and cardiovascular disease: the case is still open.
Journal of thrombosis and haemostasis : JTH 2010;8(10):2113-5.
2010: Giancarlo Castaman; Alberto Tosetto; A Cappelletti; A Goodeve; Augusto B Federici; J Batlle; D Meyer; J Goudemand; J C J Eikenboom; Reinhard Schneppenheim; U Budde; Jørgen Ingerslev; Stefan Lethagen; F Hill; I R Peake; Francesco Rodeghiero
Validation of a rapid test (VWF-LIA) for the quantitative determination of von Willebrand factor antigen in type 1 von Willebrand disease diagnosis within the European multicenter study MCMDM-1VWD.
Thrombosis research 2010;126(3):227-31.
2010: Francesco Rodeghiero; Alberto Tosetto; T Abshire; D M Arnold; B Coller; P James; C Neunert; D Lillicrap
ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders.
Journal of thrombosis and haemostasis : JTH 2010;8(9):2063-5.
2010: Giancarlo Castaman; Alberto Tosetto; J C J Eikenboom; Francesco Rodeghiero
Blood group significantly influences von Willebrand factor increase and half-life after desmopressin in von Willebrand disease Vicenza.
Journal of thrombosis and haemostasis : JTH 2010;8(9):2078-80.
2010: Benilde Cosmi; Cristina Legnani; Alberto Tosetto; Vittorio Pengo; Angelo Ghirarduzzi; Sophie Testa; D Prisco; D Poli; Armando Tripodi; Gualtiero Palareti
Sex, age and normal post-anticoagulation D-dimer as risk factors for recurrence after idiopathic venous thromboembolism in the Prolong study extension.
Journal of thrombosis and haemostasis : JTH 2010;8(9):1933-42.
2010: Benilde Cosmi; Cristina Legnani; Alberto Tosetto; Vittorio Pengo; Angelo Ghirarduzzi; Sophie Testa; Domenico Prisco; Daniela Poli; Armando Tripodi; Gualtiero Palareti
Comorbidities, alone and in combination with D-dimer, as risk factors for recurrence after a first episode of unprovoked venous thromboembolism in the extended follow-up of the PROLONG study.
Thrombosis and haemostasis 2010;103(6):1152-60.
2010: Giancarlo Castaman; Alberto Tosetto; Francesco Rodeghiero
Pregnancy and delivery in women with von Willebrand's disease and different von Willebrand factor mutations.
Haematologica 2010;95(6):963-9.
2010: Benilde Cosmi; Cristina Legnani; Alberto Tosetto; Vittorio Pengo; Angelo Ghirarduzzi; Sophie Testa; Domenico Prisco; Daniela Poli; Armando Tripodi; Francesco Marongiu; Gualtiero Palareti
Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study.
Blood 2010;115(3):481-8.
2009: G Castaman; M E Mancuso; S H Giacomelli; Alberto Tosetto; E Santagostino; P M Mannucci; F Rodeghiero
Molecular and phenotypic determinants of the response to desmopressin in adult patients with mild hemophilia A.
Journal of thrombosis and haemostasis : JTH 2009;7(11):1824-31.
2009: Alberto Tosetto; C L Balduini; M Cattaneo; E De Candia; G Mariani; A C Molinari; E Rossi; S Siragusa
Management of bleeding and of invasive procedures in patients with platelet disorders and/or thrombocytopenia: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET).
Thrombosis research 2009;124(5):e13-8.
2009: Alfonso Iorio; Walter Ageno; Benilde Cosmi; Davide Imberti; Federico Lussana; Sergio Siragusa; Daniela Tormene; Alberto Tosetto; Marco Cattaneo
Objectives and methodology: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET).
Thrombosis research 2009;124(5):e1-5.
2009: Benilde Cosmi; Cristina Legnani; Alberto Tosetto; Vittorio Pengo; Angelo Ghirarduzzi; Adriano Alatri; Domenico Prisco; Daniela Poli; Armando Tripodi; Gualtiero Palareti
Use of D-dimer testing to determine duration of anticoagulation, risk of cardiovascular events and occult cancer after a first episode of idiopathic venous thromboembolism: the extended follow-up of the PROLONG study.
Journal of thrombosis and thrombolysis 2009;28(4):381-8.
2009: Walter Ageno; David Garcia; Maria I Aguilar; James Douketis; Guido Finazzi; Davide Imberti; Alfonso Iorio; Nigel S Key; Wendy Lim; Marco Marietta; Domenico Prisco; Ravi Sarode; Sophie Testa; Alberto Tosetto; Mark Crowther
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment.
American journal of hematology 2009;84(9):584-8.
2009: Francesco Rodeghiero; Giancarlo Castaman; Alberto Tosetto
How I treat von Willebrand disease.
Blood 2009;114(6):1158-65.
2009: M Bowman; J Riddel; M L Rand; Alberto Tosetto; M Silva; P D James
Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire.
Journal of thrombosis and haemostasis : JTH 2009;7(8):1418-21.
2009: Giancarlo Castaman; Alberto Tosetto; Francesco Rodeghiero
Reduced von Willebrand factor survival in von Willebrand disease: pathophysiologic and clinical relevance.
Journal of thrombosis and haemostasis : JTH 2009;7 Suppl 1():71-4.
2009: Dan Jackson; Ian White; John B Kostis; A C Wilson; A R Folsom; K Wu; L Chambless; M Benderly; U Goldbourt; J Willeit; S Kiechl; J W G Yarnell; P M Sweetnam; P C Elwood; M Cushman; B M Psaty; R P Tracy; A Tybjaerg-Hansen; F Haverkate; M P M de Maat; S G Thompson; F G R Fowkes; A J Lee; F B Smith; V Salomaa; K Harald; V Rasi; E Vahtera; P Jousilahti; R D'Agostino; W B Kannel; P W F Wilson; G Tofler; D Levy; R Marchioli; F Valagussa; A Rosengren; L Wilhelmsen; G Lappas; H Eriksson; P Cremer; D Nagel; J D Curb; B Rodriguez; K Yano; J T Salonen; K Nyyssönen; T-P Tuomainen; B Hedblad; G Engström; G Berglund; H Loewel; W Koenig; H W Hense; T W Meade; J A Cooper; B De Stavola; C Knottenbelt; G J Miller; J A Cooper; K A Bauer; R D Rosenberg; S Sato; A Kitamura; Y Naito; H Iso; V Salomaa; K Harald; V Rasi; E Vahtera; P Jousilahti; T Palosuo; P Ducimetiere; P Amouyel; D Arveiler; A E Evans; J Ferrieres; I Juhan-Vague; A Bingham; H Schulte; G Assmann; B Cantin; B Lamarche; J-P Despres; G R Dagenais; H Tunstall-Pedoe; G D O Lowe; M Woodward; Y Ben-Shlomo; G Davey Smith; V Palmieri; J L Yeh; T W Meade; A Rudnicka; P Brennan; C Knottenbelt; J A Cooper; P Ridker; F Rodeghiero; Alberto Tosetto; J Shepherd; G D O Lowe; I Ford; M Robertson; E Brunner; M Shipley; E J M Feskens; E Di Angelantonio; S Kaptoge; S Lewington; G D O Lowe; N Sarwar; Simon G Thompson; M Walker; S Watson; I R White; A M Wood; J Danesh
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies.
Statistics in medicine 2009;28(8):1218-37.
2009: Francesco Rodeghiero; Giancarlo Castaman; Alberto Tosetto
Optimizing treatment of von Willebrand disease by using phenotypic and molecular data.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2009;():113-23.
2008: Vittorio Pengo; Gualtiero Palareti; Benilde Cosmi; Cristina Legnani; Alberto Tosetto; Adriano Alatri; Filippo Marzot; Cinzia Pegoraro; Umberto Cucchini; Sabino Iliceto
D-dimer testing and recurrent venous thromboembolism after unprovoked pulmonary embolism: A post-hoc analysis of the prolong extension study.
Thrombosis and haemostasis 2008;100(4):718-21.
2008: Patrizio Prati; Alberto Tosetto; Diego Vanuzzo; giovanni bader; Marco Casaroli; Luigi Canciani; Sergio Castellani; Pierre Jean Touboul
Carotid intima media thickness and plaques can predict the occurrence of ischemic cerebrovascular events.
Stroke; a journal of cerebral circulation 2008;39(9):2470-6.
2008: F Rodeghiero; R A Kadir; Alberto Tosetto; P D James
Relevance of quantitative assessment of bleeding in haemorrhagic disorders.
Haemophilia : the official journal of the World Federation of Hemophilia 2008;14 Suppl 3():68-75.
2008: Cristina Legnani; Gualtiero Palareti; Benilde Cosmi; Michela Cini; Alberto Tosetto; Armando Tripodi
Different cut-off values of quantitative D-dimer methods to predict the risk of venous thromboembolism recurrence: a post-hoc analysis of the PROLONG study.
Haematologica 2008;93(6):900-7.
2008: Alberto Tosetto; Giancarlo Castaman; Francesco Rodeghiero
Bleeding scores in inherited bleeding disorders: clinical or research tools?
Haemophilia : the official journal of the World Federation of Hemophilia 2008;14(3):415-22.
2008: Alberto Tosetto; Giancarlo Castaman; Francesco Rodeghiero
Evidence-based diagnosis of type 1 von Willebrand disease: a Bayes theorem approach.
Blood 2008;111(8):3998-4003.
2008: Giancarlo Castaman; Stefan Lethagen; Augusto B Federici; Alberto Tosetto; Anne Goodeve; Ulrich Budde; Javier Batlle; Dominique Meyer; Claudine Mazurier; Edith Fressinaud; Jenny Goudemand; Jeroen Eikenboom; Reinhard Schneppenheim; Jørgen Ingerslev; Zdena Vorlova; David Habart; Lars Holmberg; John Pasi; Frank Hill; Ian Peake; Francesco Rodeghiero
Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD.
Blood 2008;111(7):3531-9.
2008: Alberto Tosetto
Association or causation: the Janus face of observational research.
Journal of thrombosis and haemostasis : JTH 2008;6(4):555-7.
2008: Ida Martinelli; Tullia Battaglioli; Valerio De Stefano; D Tormene; L Valdrè; E Grandone; Alberto Tosetto; Pier M Mannucci
The risk of first venous thromboembolism during pregnancy and puerperium in double heterozygotes for factor V Leiden and prothrombin G20210A.
Journal of thrombosis and haemostasis : JTH 2008;6(3):494-8.
2008: Alberto Tosetto
Smoking in arterial and venous thrombosis: the missing link?
American journal of hematology 2008;83(2):92.
2008: Marco Ruggeri; Francesco Rodeghiero; Alberto Tosetto; Giancarlo Castaman; Francesca Scognamiglio; Guido Finazzi; Federica Delaini; Caterina Micò; Alessandro M Vannucchi; Elisabetta Antonioli; Valerio De Stefano; Tommaso Za; Luigi Gugliotta; Alessia Tieghi; Maria Gabriella Mazzucconi; Cristina Santoro; Tiziano Barbui
Postsurgery outcomes in patients with polycythemia vera and essential thrombocythemia: a retrospective survey.
Blood 2008;111(2):666-71.
2007: Francesco Baudo; Francesco de Cataldo; G Mostarda; Angelo Ghirarduzzi; M Molinatti; Vittorio Pengo; D Poli; Alberto Tosetto; E Tiraferri; E Morra
Management of patients on long-term oral anticoagulant therapy undergoing elective surgery: survey of the clinical practice in the Italian anticoagulation clinics.
Internal and emergency medicine 2007;2(4):280-4.
2007: Francesco Rodeghiero; Alberto Tosetto; Giancarlo Castaman
How to estimate bleeding risk in mild bleeding disorders.
Journal of thrombosis and haemostasis : JTH 2007;5 Suppl 1():157-66.
2007: Montse Piñol; Miquel Sales; Marta Costa; Alberto Tosetto; Maria Teresa Canciani; Augusto B Federici
Evaluation of a new turbidimetric assay for von Willebrand factor activity useful in the general screening of von Willebrand disease.
Haematologica 2007;92(5):712-3.
2007: C Visco; Ilaria Giaretta; M Ruggeri; domenico madeo; Alberto Tosetto; Francesco Rodeghiero
Un-mutated IgVH in chronic lymphocytic leukemia is associated with a higher risk of immune thrombocytopenia.
Leukemia 2007;21(5):1092-3.
2007: Alberto Tosetto; Francesco Rodeghiero; Giancarlo Castaman; M Bernardi; K Bertoncello; Anne C Goodeve; Augusto B Federici; Javier Batlle; Dominique Meyer; Claudine Mazurier; Jenny Goudemand; J C J Eikenboom; Reinhard Schneppenheim; Ulrich Budde; Jørgen Ingerslev; Zdena Vorlova; David Habart; Lars Holmberg; Stefan Lethagen; John Pasi; Frank Hill; Ian R Peake
Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD).
Journal of thrombosis and haemostasis : JTH 2007;5(4):715-21.
2007: Alberto Tosetto; Giancarlo Castaman; Francesco Rodeghiero
Assessing bleeding in von Willebrand disease with bleeding score.
Blood reviews 2007;21(2):89-97.
2007: J Danesh; S Erqou; M Walker; Simon G Thompson; R Tipping; C Ford; S Pressel; G Walldius; I Jungner; A R Folsom; Lloyd E Chambless; M Knuiman; P H Whincup; S G Wannamethee; R W Morris; J Willeit; S Kiechl; P Santer; A Mayr; Nicholas J Wald; Shah Ebrahim; D A Lawlor; J W G Yarnell; J Gallacher; E Casiglia; V Tikhonoff; Paul Nietert; S E Sutherland; D L Bachman; J E Keil; M Cushman; B M Psaty; R P Tracy; A Tybjaerg-Hansen; B G Nordestgaard; R Frikke-Schmidt; S Giampaoli; L Palmieri; S Panico; D Vanuzzo; L Pilotto; L Simons; J McCallum; Y Friedlander; F G R Fowkes; A J Lee; F B Smith; J Taylor; J Guralnik; C Phillips; R Wallace; D Blazer; K T Khaw; J H Jansson; C Donfrancesco; V Salomaa; K Harald; P Jousilahti; E Vartiainen; M Woodward; R B D'Agostino; Philip A Wolf; R S Vasan; M J Pencina; E M Bladbjerg; T Jorgensen; L Moller; J Jespersen; R Dankner; A Chetrit; F Lubin; Annika Rosengren; L Wilhelmsen; G Lappas; H Eriksson; C Bjorkelund; P Cremer; D Nagel; R Tilvis; T Strandberg; B Rodriguez; L M Bouter; R J Heine; J M Dekker; G Nijpels; C D A Stehouwer; E Rimm; J Pai; S Sato; H Iso; A Kitamura; H Noda; U Goldbourt; V Salomaa; J T Salonen; K Nyyssönen; Tomi-Pekka Tuomainen; D Deeg; J L Poppelaars; T Meade; J Cooper; B Hedblad; G Berglund; G Engstrom; A Döring; W Koenig; C Meisinger; W Mraz; L Kuller; R Selmer; A Tverdal; W Nystad; R Gillum; M Mussolino; S Hankinson; J Manson; B De Stavola; C Knottenbelt; J A Cooper; K A Bauer; R D Rosenberg; S Sato; Y Naito; I Holme; H Nakagawa; H Miura; P Ducimetiere; X Jouven; C Crespo; M Garcia-Palmieri; P Amouyel; D Arveiler; A Evans; J Ferrieres; H Schulte; G Assmann; J Shepherd; C Packard; N Sattar; B Cantin; B Lamarche; J-P Després; G R Dagenais; E Barrett-Connor; D Wingard; R Bettencourt; V Gudnason; Thor Aspelund; G Sigurdsson; B Thorsson; M Trevisan; J Witteman; I Kardys; Monique Breteler; Albert Hofman; H Tunstall-Pedoe; R Tavendale; G D O Lowe; Y Ben-Shlomo; B V Howard; Y Zhang; L Best; J Umans; A Onat; T W Meade; I Njolstad; E Mathiesen; M L Lochen; T Wilsgaard; J M Gaziano; M Stampfer; P Ridker; H Ulmer; G Diem; H Concin; F Rodeghiero; Alberto Tosetto; E Brunner; M Shipley; J Buring; S M Cobbe; I Ford; M Robertson; Y He; A M Ibanez; E J M Feskens; D Kromhout; R Collins; E Di Angelantonio; S Kaptoge; S Lewington; L Orfei; L Pennells; P Perry; K Ray; N Sarwar; M Scherman; A Thompson; S Watson; F Wensley; I R White; A M Wood
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases.
European journal of epidemiology 2007;22(12):839-69.
2007: Giancarlo Castaman; Eugenia Biguzzi; Cristina Razzari; Alberto Tosetto; Gessica Fontana; Daniela Asti; Vincenzo Brancaccio; D Castori; David A Lane; Elena M Faioni
Association of protein S p.Pro667Pro dimorphism with plasma protein S levels in normal individuals and patients with inherited protein S deficiency.
Thrombosis research 2007;120(3):421-6.
2006: Ida Martinelli; Tullia Battaglioli; Alberto Tosetto; Cristina Legnani; L Sottile; Rossella Ghiotto; Pier M Mannucci
Prothrombin A19911G polymorphism and the risk of venous thromboembolism.
Journal of thrombosis and haemostasis : JTH 2006;4(12):2582-6.
2006: Gualtiero Palareti; Benilde Cosmi; Cristina Legnani; Alberto Tosetto; Carlotta Brusi; Alfonso Iorio; Vittorio Pengo; Angelo Ghirarduzzi; Corrado Pattacini; Sophie Testa; Anthonie W A Lensing; Armando Tripodi
D-dimer testing to determine the duration of anticoagulation therapy.
The New England journal of medicine 2006;355(17):1780-9.
2006: Giancarlo Castaman; Francesco Rodeghiero; Alberto Tosetto; A Cappelletti; Francesco Baudo; J C J Eikenboom; Augusto B Federici; Stefan Lethagen; S Linari; Jeanne M Lusher; M Nishino; P Petrini; A Srivastava; J S Ungerstedt
Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study.
Journal of thrombosis and haemostasis : JTH 2006;4(10):2164-9.
2006: Alberto Tosetto
Enoxaparin vs. nadroparin for venous thromboembolism prevention: too close to tell?
Journal of thrombosis and haemostasis : JTH 2006;4(8):1691-2.
2006: Francesca Elice; Roberto Raimondi; Alberto Tosetto; Anna D'Emilio; Eros Di Bona; Andrea Piccin; Francesco Rodeghiero
Prolonged overall survival with second on-demand autologous transplant in multiple myeloma.
American journal of hematology 2006;81(6):426-31.
2006: Alberto Tosetto; Francesco Rodeghiero; Giancarlo Castaman; Anne C Goodeve; Augusto B Federici; Javier Batlle; Dominique Meyer; Edith Fressinaud; Claudine Mazurier; Jenny Goudemand; J C J Eikenboom; Reinhard Schneppenheim; Ulrich Budde; Jørgen Ingerslev; Zdena Vorlova; David Habart; Lars Holmberg; Stefan Lethagen; John Pasi; Frank Hill; Ian R Peake
A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD).
Journal of thrombosis and haemostasis : JTH 2006;4(4):766-73.
2006: Patrizio Prati; Marco Casaroli; A Bignamini; S Scotti; L Canciani; Maurizio Ruscio; M Balestrieri; N Bornstein; O Zanetti; Alberto Tosetto; Sergio Castellani; L Pantoni; Pierre Jean Touboul; D Inzitari
Cognitive impairment and carotid atherosclerosis in a general Italian midlife and old population.
Neuroepidemiology 2006;27(1):33-8.
2005: Francesco Rodeghiero; Giancarlo Castaman; Alberto Tosetto; Javier Batlle; Francesco Baudo; A Cappelletti; P Casana; N De Bosch; J C J Eikenboom; Augusto B Federici; Stefan Lethagen; S Linari; A Srivastava
The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study.
Journal of thrombosis and haemostasis : JTH 2005;3(12):2619-26.
2005: John Danesh; Sarah Lewington; Simon G Thompson; Gordon D O Lowe; Rory Collins; John B Kostis; A C Wilson; A R Folsom; K Wu; M Benderly; U Goldbourt; J Willeit; S Kiechl; J W G Yarnell; P M Sweetnam; P C Elwood; M Cushman; B M Psaty; R P Tracy; A Tybjaerg-Hansen; F Haverkate; M P M de Maat; F G R Fowkes; A J Lee; F B Smith; V Salomaa; K Harald; R Rasi; E Vahtera; P Jousilahti; J Pekkanen; R D'Agostino; W B Kannel; P W F Wilson; G Tofler; C L Arocha-Piñango; A Rodriguez-Larralde; E Nagy; M Mijares; R Espinosa; E Rodriquez-Roa; Elena Ryder; M P Diez-Ewald; G Campos; V Fernandez; E Torres; R Marchioli; F Valagussa; Annika Rosengren; L Wilhelmsen; G Lappas; H Eriksson; P Cremer; D Nagel; J D Curb; B Rodriguez; K Yano; J T Salonen; K Nyyssönen; Tomi-Pekka Tuomainen; B Hedblad; P Lind; H Loewel; W Koenig; T W Meade; J A Cooper; B De Stavola; C Knottenbelt; G J Miller; J A Cooper; K A Bauer; R D Rosenberg; S Sato; A Kitamura; Y Naito; T Palosuo; P Ducimetiere; P Amouyel; D Arveiler; A E Evans; J Ferrieres; I Juhan-Vague; A Bingham; H Schulte; G Assmann; B Cantin; B Lamarche; J-P Després; G R Dagenais; H Tunstall-Pedoe; M Woodward; Y Ben-Shlomo; G Davey Smith; V Palmieri; J L Yeh; A Rudnicka; P Ridker; F Rodeghiero; Alberto Tosetto; J Shepherd; I Ford; M Robertson; E Brunner; M Shipley; E J M Feskens; D Kromhout; A Dickinson; B Ireland; K Juzwishin; S Kaptoge; S Lewington; A Memon; N Sarwar; M Walker; J Wheeler; I White; A Wood
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.
JAMA : the journal of the American Medical Association 2005;294(14):1799-809.
2005: Alberto Tosetto; Patrizio Prati; Claudio Baracchini; Renzo Manara; Francesco Rodeghiero
Age-adjusted reference limits for carotid intima-media thickness as better indicator of vascular risk: population-based estimates from the VITA project.
Journal of thrombosis and haemostasis : JTH 2005;3(6):1224-30.
2005: Giancarlo Castaman; Rossella Ghiotto; Alberto Tosetto; Francesco Rodeghiero
Bbeta 14 Arg --> Cys variant dysfibrinogen and its association with thrombosis.
Journal of thrombosis and haemostasis : JTH 2005;3(2):409-10.
2005: Christoph L Klein; János Márki-Zay; Philippe Corbisier; David Gancberg; Susan Cooper; Donato Gemmati; Walter-Michael Halbmayer; Steve Kitchen; Béla Melegh; Michael Neumaier; Johannes Oldenburg; Elisabeth Oppliger Leibundgut; Pieter H Reitsma; Sandra Rieger; Heinz Schimmel; Michael Spannagl; Attilia Tordai; Alberto Tosetto; Sophie Visvikis; Renata Zadro; Christine Mannhalter
Reference materials (RMs) for analysis of the human factor II (prothrombin) gene G20210A mutation.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2005;43(8):862-8.
2004: Alberto Tosetto; Monica Simioni; domenico madeo; Francesco Rodeghiero
Intraindividual consistency of the activated protein C resistance phenotype.
British journal of haematology 2004;126(3):405-9.
2003: Giancarlo Castaman; Elena M Faioni; Alberto Tosetto; Francesco Bernardi
The factor V HR2 haplotype and the risk of venous thrombosis: a meta-analysis.
Haematologica 2003;88(10):1182-9.
2003: Marco Ruggeri; Alberto Tosetto; Maurizio Frezzato; Francesco Rodeghiero
The rate of progression to polycythemia vera or essential thrombocythemia in patients with erythrocytosis or thrombocytosis.
Annals of internal medicine 2003;139(6):470-5.
2003: Alberto Tosetto; Maurizio Frezzato; Francesco Rodeghiero
Prevalence and risk factors of non-fatal venous thromboembolism in the active population of the VITA Project.
Journal of thrombosis and haemostasis : JTH 2003;1(8):1724-9.
2002: Marco Ruggeri; Heinz Gisslinger; Alberto Tosetto; Claudia Rintelen; Christine Mannhalter; Ingrid Pabinger; Navide Heis; Giancarlo Castaman; Edoardo Missiaglia; Klaus Lechner; Francesco Rodeghiero
Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
American journal of hematology 2002;71(1):1-6.
2001: Giancarlo Castaman; Alberto Tosetto; M Simioni; M Ruggeri; domenico madeo; Francesco Rodeghiero
Phenotypic APC resistance in carriers of the A20210 prothrombin mutation is associated with an increased risk of venous thrombosis.
Thrombosis and haemostasis 2001;86(3):804-8.
2001: M Ruggeri; Alberto Tosetto; G Castaman; F Rodeghiero
Pulmonary embolism after pregnancy in a patient with polycythemia vera.
American journal of hematology 2001;67(3):216-7.
2001: M Ruggeri; Alberto Tosetto; G Castaman; F Rodeghiero
Congenital absence of the inferior vena cava: a rare risk factor for idiopathic deep-vein thrombosis.
Lancet 2001;357(9254):441.
2000: M Ruggeri; G Castaman; Alberto Tosetto; F Rodeghiero
Two families with combined homozygous/heterozygous factor V Leiden mutation and heterozygous G20210A factor II variant.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2000;11(8):783-4.
2000: Alberto Tosetto; Giancarlo Castaman; Antonio Cappellari; Francesco Rodeghiero
The VITA Project: heritability of resistance to activated protein C. Vincenza Thrombophilia and Arteriosclerosis.
Thrombosis and haemostasis 2000;84(5):811-4.
2000: G Castaman; M Ruggeri; Alberto Tosetto; F Rodeghiero
Heterogeneity of activated protein C resistance phenotype in subjects with compound heterozygosity for HR2 haplotype and FV Leiden mutation (R506Q) in factor V gene.
Thrombosis and haemostasis 2000;84(2):357-8.
2000: Giancarlo Castaman; Alberto Tosetto; Antonio Cappellari; M Ruggeri; Francesco Rodeghiero
The A20210 allele in the prothrombin gene enhances the risk of venous thrombosis in carriers of inherited protein S deficiency.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2000;11(4):321-6.
1999: Alberto Tosetto; Edoardo Missiaglia; Maurizio Frezzato; Francesco Rodeghiero
The VITA project: prothrombin G20210A mutation and venous thromboembolism in the general population.
Thrombosis and haemostasis 1999;82(5):1395-8.
1999: G Castaman; Alberto Tosetto; M Ruggeri; F Rodeghiero
Pseudohomozygosity for activated protein C resistance is a risk factor for venous thrombosis.
British journal of haematology 1999;106(1):232-6.
1999: Francesco Rodeghiero; Alberto Tosetto
Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism.
Annals of internal medicine 1999;130(8):643-50.
1998: Alberto Tosetto; Francesco Rodeghiero; Ida Martinelli; V De Stefano; Edoardo Missiaglia; P Chiusolo; P M Mannucci
Additional genetic risk factors for venous thromboembolism in carriers of the factor V Leiden mutation.
British journal of haematology 1998;103(3):871-6.
1998: M Ruggeri; G Finazzi; Alberto Tosetto; S Riva; Francesco Rodeghiero; T Barbui
No treatment for low-risk thrombocythaemia: results from a prospective study.
British journal of haematology 1998;103(3):772-7.
1998: Giancarlo Castaman; M Ruggeri; Alberto Tosetto; Francesco Rodeghiero
Low risk of venous thrombosis in two families with combined type I plasminogen deficiency and factor V R506Q mutation.
American journal of hematology 1998;57(4):344-7.
1997: R Vangelisti; O Pagnacco; G Ristagno; M Ruggeri; Alberto Tosetto; Giancarlo Castaman; Francesco Rodeghiero
[Prevention of hemorrhage and dental treatment of patients with congenital or acquired coagulopathies].
Minerva stomatologica 1997;46(11):621-6.
1997: Alberto Tosetto; M Ruggeri; Giancarlo Castaman; Francesco Rodeghiero
Inherited abnormalities of blood coagulation in juvenile stroke. A case-control study.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1997;8(7):397-402.
1997: Alberto Tosetto; Edoardo Missiaglia; E Gatto; Francesco Rodeghiero
The VITA project: phenotypic resistance to activated protein C and FV Leiden mutation in the general population. Vicenza Thrombophilia and Atherosclerosis.
Thrombosis and haemostasis 1997;78(2):859-63.
1997: Francesco Rodeghiero; Alberto Tosetto
The epidemiology of inherited thrombophilia: the VITA Project. Vicenza Thrombophilia and Atherosclerosis Project.
Thrombosis and haemostasis 1997;78(1):636-40.
1997: Alberto Tosetto; Edoardo Missiaglia; Maurizio Frezzato; Francesco Rodeghiero
The VITA project: C677T mutation in the methylene-tetrahydrofolate reductase gene and risk of venous thromboembolism.
British journal of haematology 1997;97(4):804-6.
1997: M Ruggeri; C Schiavotto; Giancarlo Castaman; Alberto Tosetto; Francesco Rodeghiero
Gestational thrombocytopenia: a prospective study.
Haematologica 1997;82(3):341-2.
1997: M Ruggeri; G Castaman; Alberto Tosetto; F Rodeghiero
Low prevalence of thrombophilic coagulation defects in patients with deep vein thrombosis of the upper limbs.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1997;8(3):191-4.
1997: Alberto Tosetto; E Gatto; F Rodeghiero
Influence of cholesterol, triglycerides and fibrinogen on AT III, PC, HC-II and plasminogen measurement.
Thrombosis and haemostasis 1997;77(4):804.
1996: G Castaman; M Ruggeri; Alberto Tosetto; F Bernardi; F Rodeghiero
The Ser460Pro substitution of the protein S (PS) gene in rare in Italian patients with type IIa PS deficiency.
Blood 1996;88(9):3666-7.
1996: Giancarlo Castaman; M Ruggeri; Alberto Tosetto; Edoardo Missiaglia; Francesco Rodeghiero
Thrombosis in patients with heterozygous and homozygous factor XII deficiency is not explained by the associated presence of factor V Leiden.
Thrombosis and haemostasis 1996;76(2):275.
1996: F Rodeghiero; Alberto Tosetto
The VITA Project: population-based distributions of protein C, antithrombin III, heparin-cofactor II and plasminogen--relationship with physiological variables and establishment of reference ranges.
Thrombosis and haemostasis 1996;76(2):226-33.
1996: Maurizio Frezzato; Alberto Tosetto; Francesco Rodeghiero
Validated questionnaire for the identification of previous personal or familial venous thromboembolism.
American journal of epidemiology 1996;143(12):1257-65.
1996: T Izumi; T Hashiguchi; G Castaman; Alberto Tosetto; F Rodeghiero; A Girolami; Akitada Ichinose
Type I factor XIII deficiency is caused by a genetic defect of its b subunit: insertion of triplet AAC in exon III leads to premature termination in the second Sushi domain.
Blood 1996;87(7):2769-74.
1996: Ida Martinelli; G Landi; Giuliana Merati; R Cella; Alberto Tosetto; Pier M Mannucci
Factor V gene mutation is a risk factor for cerebral venous thrombosis.
Thrombosis and haemostasis 1996;75(3):393-4.
1995: Giancarlo Castaman; A Lattuada; M Ruggeri; Alberto Tosetto; P M Mannucci; Francesco Rodeghiero
Platelet von Willebrand factor abnormalities in myeloproliferative syndromes.
American journal of hematology 1995;49(4):289-93.
1995: Alberto Tosetto; F Rodeghiero
Diagnosis of APC resistance in patients on oral anticoagulant therapy.
Thrombosis and haemostasis 1995;73(4):732-3.
1995: Alberto Tosetto; Maurizio Frezzato; Francesco Rodeghiero
Family history and inherited thrombophilia.
British journal of haematology 1995;89(1):227-8.
1995: Alberto Tosetto; Francesco Rodeghiero; E Gatto; C Manotti; T Poli
An acquired hemorrhagic disorder of fibrin crosslinking due to IgG antibodies to FXIII, successfully treated with FXIII replacement and cyclophosphamide.
American journal of hematology 1995;48(1):34-9.
1994: Alberto Tosetto; E Gatto; M T Masiero; Francesco Rodeghiero
Parallel line bioassay or single-point calibration for the establishment of reference ranges.
Thrombosis research 1994;75(4):479-83.
1993: Alberto Tosetto; Giancarlo Castaman; Francesco Rodeghiero
Acquired plasma factor XIII deficiencies.
Haematologica 1993;78(6 Suppl 2):5-10.
1993: Alberto Tosetto; M Ruggeri; C Schiavotto; G Pellizzari; Francesco Rodeghiero
The clinical significance of the antiplatelet antibody test based on results for 265 thrombocytopenic patients.
Haematologica 1993;78(6 Suppl 2):41-6.
1993: F Rodeghiero; Alberto Tosetto
Some remarks on the epidemiology of thrombotic disorders.
Thrombosis and haemostasis 1993;69(5):527-9.
1992: Giancarlo Castaman; Alberto Tosetto; Francesco Rodeghiero
Effectiveness of high-dose intravenous immunoglobulin in a case of acquired von Willebrand syndrome with chronic melena not responsive to desmopressin and factor VIII concentrate.
American journal of hematology 1992;41(2):132-6.
1992: B Casali; F Rodeghiero; Alberto Tosetto; B Palmieri; R Immovilli; C Ghedini; P Rivasi
Fibrin glue from single-donation autologous plasmapheresis.
Transfusion 1992;32(7):641-3.
1992: F Rodeghiero; G Castaman; M Ruggeri; Alberto Tosetto
Thrombosis in subjects with homozygous and heterozygous factor XII deficiency.
Thrombosis and haemostasis 1992;67(5):590-1.
1992: Francesco Rodeghiero; Giancarlo Castaman; M Ruggeri; Alberto Tosetto
The bleeding time in normal subjects is mainly determined by platelet von Willebrand factor and is independent from blood group.
Thrombosis research 1992;65(4-5):605-15.
1991: F Rodeghiero; M Ruggeri; Alberto Tosetto; E Dini
[Essential thrombocythemia: clinical aspects].
Haematologica 1991;76 Suppl 3():361-4.
1991: Francesco Rodeghiero; Alberto Tosetto; Eros Di Bona; Giancarlo Castaman
Clinical pharmacokinetics of a placenta-derived factor XIII concentrate in type I and type II factor XIII deficiency.
American journal of hematology 1991;36(1):30-4.
1991: Alberto Tosetto; Francesco Rodeghiero
Parallel line bioassay in a coagulation laboratory. A program for personal computer use and an example application to Ristocetin Cofactor assay.
Clinical and laboratory haematology 1991;13(4):371-7.
1990: Francesco Rodeghiero; Giancarlo Castaman; Alberto Tosetto
von Willebrand factor antigen is less sensitive than ristocetin cofactor for the diagnosis of type I von Willebrand disease--results based on an epidemiological investigation.
Thrombosis and haemostasis 1990;64(3):349-52.
1990: F Rodeghiero; Alberto Tosetto
Factor XIII subunit B deficiency.
British journal of haematology 1990;76(2):317.
1990: Francesco Rodeghiero; Giancarlo Castaman; Alberto Tosetto; A Lattuada; P M Mannucci
Platelet von Willebrand factor assay: results using two methods for platelet lysis.
Thrombosis research 1990;59(2):259-67.
1989: Francesco Rodeghiero; Giancarlo Castaman; Alberto Tosetto; M Ruggeri; Eros Di Bona
Triton X contaminating platelet lysate critically affects the measurement of von Willebrand factor ristocetin cofactor activity.
Thrombosis research 1989;55(4):521-6.